Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03457870
Other study ID # Change 2018
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 18, 2018
Est. completion date March 23, 2020

Study information

Verified date February 2021
Source King's College London
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Extended bouts of periodic mastication and intermittent energy restriction (IER) may improve cognitive performance in the context of adult hippocampal neurogenesis in an ageing population. A randomised controlled parallel design trial will determine the impact of a 3 month IER diet (2 consecutive days of very low calorie diet and 5 days of normal eating) and a mastication intervention (1 piece of gum chewed for 10 minutes 3 times a day) in comparison to a control on neurogenesis-associated cognitive measures and circulating levels of the anti-ageing protein Klotho.


Description:

Nutrition and human health are strongly related. Altering overabundance through fasting/calorie-restricted diets has profound effects on homeostasis, tissue regeneration, and cancer. Tissue stem cells respond to the physiological changes that occur during fasting through dynamic shifts in their metabolism. Restricting energy intake in mice or introducing mutations in nutrient-sensing pathways can extend lifespans by as much as 50%. Post-mortems reveal that tumours, heart problems, neurodegeneration and metabolic disease are generally reduced/delayed in long-lived mice. Therefore, extending lifespan by energy restriction (ER) also seems to increase 'healthspan', the time lived without chronic age-related conditions. These insights have hardly made a dent in human medicine. Molecular and cellular insights should be established in humans to validate interventions such as ER to delay ageing and associated conditions e.g. cognitive decline (Murphy et al., 2014). Stem cells from the central nervous system also respond to ER. Recently, the Thuret lab have found that ER, in the absence of malnutrition, promotes hippocampal stem cells to proliferate and differentiate into new-born neurons. Because these new postnatal hippocampal neurons have been shown to play a role in cognition, ER also promoted enhanced cognition in rodents (Zainuddin et al., 2012; de Lucia et al., 2017; Thuret et al., 2012). This phenomenon of neurogenesis, the process by which new neurons are generated from neural stem cells, is also occurring in humans (Spalding et al., 2013). It is a tightly regulated process occurring in the mammalian hippocampus which is an environmentally responsive brain structure known to regulate learning, memory and mood. Proposed functions of adult hippocampal neurogenesis (AHN). include enhancing recognition memory, the ability to recognise previously encountered stimuli, and pattern separation, the ability to differentially encode small changes in similar inputs (Clelland et alk., 2009; Sahay et al., 2011). It has been posited that calorie restriction may increase neurogenesis as a "cellular relic" of intermittent feeding patterns during evolution as a response to alternating periods of famine and abundant food (Murphy & Thuret, 2015). Human trials have found significant improvements in verbal recognition memory after 30% reduction in calorie intake (Witte et al., 2009). Also, intermittent fasting in humans has been associated with significant increases in brain activation volume in areas involved in brain function control and plasticity(Belaïch et al., 2016). Food texture and mastication have also been implicated in AHN and cognitive ability (Smith et al., 2016). Decreased mastication due to the removal of molars and edentulism in both humans and animals have a negative impact on AHN and associated cognition. Human populations, in particular, have shown a close association between masticatory function, cognitive status and age-related neurodegeneration in the elderly (Miura et al., 2003). The exact mechanism by which mastication affects cognition is unknown. Research question: In older, overweight participants does IER and/or extended periods of mastication enhance performance inhippocampus-dependent memory tasks and increase anti-ageing marker Klotho? Objectives: 1. A randomised controlled parallel-design trial will determine the impact of an IER diet (2 consecutive days of a very low calorie diet, 5 days of normal healthy eating for 3 months) and/or extended periods of mastication (10 minutes 3 times a day for 3 months) compared to a control group (continued habitual eating behaviour, dietary patterns) on primary outcome variables (MST and Klotho) in older, healthy participants with overweight or class I obesity. 2. To assess the impact of an IER diet and extended periods of mastication on secondary outcomes variables including body composition, mood and sleep. 3. To explore whether extended periods of mastication can be utilised as a weight loss/fasting aid.


Recruitment information / eligibility

Status Completed
Enrollment 123
Est. completion date March 23, 2020
Est. primary completion date March 23, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 60 Years and older
Eligibility Inclusion Criteria: - Male and female subjects. - 60+ years of age at the time of consent. - BMI 25-35. Exclusion Criteria: - Subject is unable to understand the participant information sheet. - Subject is unable to understand and/or completely perform the cognitive testing. - Chews more than 3 sticks of gum per month, including nicotine replacement gum. - Unable to provide written informed consent. - Impaired vision that is not corrected. - Does not agree to maintain their habitual exercise routine. - Is not in general good health on the basis of medical history. - Unwilling to chew gum for 3 times a day for 12 weeks. - Unwilling to maintain an intermittent fasting diet regime. - Unwilling to have blood taken. - History of or are currently diagnosed with a significant psychiatric disorder (e.g. schizophrenia, anxiety, PTSD). - Subject has any neurological disorder that could produce cognitive deterioration (e.g. Alzheimer's disease, Parkinson's disease, stroke). - History of traumatic brain injury, stroke or any other medical conditions causing cognitive impairment. - Has uncontrolled epilepsy or is prone to fainting. - Participated in a weight management drug trial in previous 3 months. - Has undergone bariatric surgery. - Known or suspected of alcohol abuse defined as >14 drinks per week (1 drink = 1 pint of beer, 1 large glass of wine or 50ml spirit). - Gastrointestinal or liver disease. - Subject has a sleep disorder or an occupation where sleep during the overnight hours is irregular. - Subjects taking the following prescription medications: Donepezil (Aricept), Galantamine (Reminyl), Rivastigmine (Exelon), Tacrine (Cognex), Bethanechol (Urecholine), Memantine (Namenda) Selegiline (Eldepryl) or any other medication for cognitive impairment. - Subject has a known sensitivity to the study product. - Individual has a condition the chief investigator believes would interfere with his or her ability to provide informed consent, comply with the study protocol, might confound the interpretation of study results or put the subject at undue risk.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Intermittent Energy Restriction
Dietary advice to follow a 5:2 diet.
Chewing
Asked to chew 1 piece of gum for 10 minutes 3 times a day.
Chewing + Intermittent Energy Restriction
Dietary advice to follow a 5:2 diet. Asked to chew 1 piece of gum for 10 minutes 3 times a day.

Locations

Country Name City State
United Kingdom Diabetes & Nutritional Sciences Division, King's College London, Franklin-Wilkins Building, 150 Stamford St London England

Sponsors (3)

Lead Sponsor Collaborator
King's College London Mars, Inc., Medical Research Council

Country where clinical trial is conducted

United Kingdom, 

References & Publications (4)

Akazawa Y, Kitamura T, Fujihara Y, Yoshimura Y, Mitome M, Hasegawa T. Forced mastication increases survival of adult neural stem cells in the hippocampal dentate gyrus. Int J Mol Med. 2013 Feb;31(2):307-14. doi: 10.3892/ijmm.2012.1217. Epub 2012 Dec 18. — View Citation

Murphy T, Dias GP, Thuret S. Effects of diet on brain plasticity in animal and human studies: mind the gap. Neural Plast. 2014;2014:563160. doi: 10.1155/2014/563160. Epub 2014 May 12. Review. — View Citation

Smith, N., Miquel-Kergoat, S. & Thuret, S., 2016. The impact of mastication on cognition: Evidence for intervention and the role of adult hippocampal neurogenesis. Nutrition and Aging, 3(2-4), pp.115-123

Witte AV, Fobker M, Gellner R, Knecht S, Flöel A. Caloric restriction improves memory in elderly humans. Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1255-60. doi: 10.1073/pnas.0808587106. Epub 2009 Jan 26. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Adverse events Baseline until endpoint: Day 84
Primary Serum Klotho concentration Anti-ageing longevity protein Baseline
Primary Serum Klotho concentration Anti-ageing longevity protein Day 42
Primary Serum Klotho concentration Anti-ageing longevity protein Day 84
Primary Mnemonic Similarity Task Neurogenesis-associated cognition Baseline
Primary Mnemonic Similarity Task Neurogenesis-associated cognition Day 42
Secondary Body weight Baseline
Secondary Body weight Day 42
Secondary Body weight Day 84
Secondary Body fat percentage Baseline
Secondary Body fat percentage Day 42
Secondary Body fat percentage Day 84
Secondary Body Mass Index Baseline
Secondary Body Mass Index Day 42
Secondary Body Mass Index Day 84
Secondary Waist circumference Baseline
Secondary Waist circumference Day 42
Secondary Waist circumference Day 84
Secondary Hip circumference Baseline
Secondary Hip circumference Day 42
Secondary Hip circumference Day 84
Secondary Patient Health Questionnaire Questionnaire Baseline
Secondary Patient Health Questionnaire Questionnaire Day 42
Secondary Patient Health Questionnaire Questionnaire Day 84
Secondary Zung Self-Rating Anxiety Scale Questionnaire - Scale can be scored from 20 (normal) to 80 (extreme anxiety levels). The total score is reported. Baseline
Secondary Zung Self-Rating Anxiety Scale Questionnaire Day 42
Secondary Zung Self-Rating Anxiety Scale Questionnaire Day 84
Secondary Pittsburgh Sleep Quality Index Questionnaire Baseline
Secondary Pittsburgh Sleep Quality Index Questionnaire Day 42
Secondary Pittsburgh Sleep Quality Index Questionnaire Day 84
Secondary Plasma glucose concentration Fasting Baseline
Secondary Plasma glucose concentration Fasting Day 42
Secondary Plasma glucose concentration Fasting Day 84
Secondary Cholesterol Fasting Baseline
Secondary Cholesterol Fasting Day 42
Secondary Cholesterol Fasting Day 84
Secondary Triglycerides Fasting Baseline
Secondary Triglycerides Fasting Day 42
Secondary Triglycerides Fasting Day 84
Secondary High Density Lipoprotein Fasting Baseline
Secondary High Density Lipoprotein Fasting Day 42
Secondary High Density Lipoprotein Fasting Day 84
Secondary Low Density Lipoprotein Fasting Baseline
Secondary Low Density Lipoprotein Fasting Day 42
Secondary Low Density Lipoprotein Fasting Day 84
Secondary Total/HDL Cholesterol Ratio Fasting Baseline
Secondary Total/HDL Cholesterol Ratio Fasting Day 42
Secondary Total/HDL Cholesterol Ratio Fasting Day 84
Secondary Plasma adiponectin concentration Fasting Baseline
Secondary Plasma adiponectin concentration Fasting Day 42
Secondary Plasma adiponectin concentration Fasting Day 84
Secondary Plasma leptin concentration Fasting Baseline
Secondary Plasma leptin concentration Fasting Day 42
Secondary Plasma leptin concentration Fasting Day 84
Secondary Plasma beta-hydroxybutrate concentration Fasting Baseline
Secondary Plasma beta-hydroxybutrate concentration Fasting Day 42
Secondary Plasma beta-hydroxybutrate concentration Fasting Day 84
Secondary Plasma total cholesterol concentration Fasting Baseline
Secondary Plasma total cholesterol concentration Fasting Day 42
Secondary Plasma total cholesterol concentration Fasting Day 84
Secondary Plasma low density lipoprotein (LDL) cholesterol concentration Fasting Baseline
Secondary Plasma LDL cholesterol concentration Fasting Day 42
Secondary Plasma LDL cholesterol concentration Fasting Day 84
Secondary Plasma high density lipoprotein (HDL) cholesterol concentration Fasting Baseline
Secondary Plasma HDL cholesterol concentration Fasting Day 42
Secondary Plasma HDL cholesterol concentration Fasting Day 84
Secondary Plasma triglyceride concentration Fasting Baseline
Secondary Plasma triglyceride concentration Fasting Day 42
Secondary Plasma triglyceride concentration Fasting Day 84
Secondary Plasma total cholesterol:HDL cholesterol ratio Fasting Baseline
Secondary Plasma total cholesterol:HDL cholesterol ratio Fasting Day 42
Secondary Plasma total cholesterol:HDL cholesterol ratio Fasting Day 84
See also
  Status Clinical Trial Phase
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Recruiting NCT06032065 - Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD) Phase 3
Completed NCT05293730 - Trial of the Impact of the Electronic Frailty Integrated With Social Needs N/A
Recruiting NCT03932162 - Gene Expression Changes In Young and Geriatric Skin Early Phase 1
Completed NCT04064528 - Effects of Age on Amino Acid Delivery to Tendon N/A
Completed NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT06029920 - Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment N/A
Recruiting NCT05566938 - Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly N/A
Recruiting NCT05543980 - Leg Heat Therapy in Elderly Individuals Phase 2
Completed NCT04894929 - Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement N/A
Not yet recruiting NCT06071130 - Emotion, Aging, and Decision Making N/A
Enrolling by invitation NCT04641663 - Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST) N/A
Completed NCT04088006 - The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity N/A
Completed NCT03695081 - Patient Pathway Pharmacist - Optimal Drug-related Care N/A
Recruiting NCT05424263 - Acetate and Age-associated Arterial Dysfunction Phase 2
Completed NCT05601713 - Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling N/A
Completed NCT04551339 - Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19 N/A
Recruiting NCT04997577 - Speech Perception and High Cognitive Demand N/A
Completed NCT05922475 - Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training N/A
Completed NCT04015479 - Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults N/A